1. Home
  2. EVR vs TECH Comparison

EVR vs TECH Comparison

Compare EVR & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evercore Inc.

EVR

Evercore Inc.

HOLD

Current Price

$288.42

Market Cap

13.7B

Sector

Finance

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$72.28

Market Cap

11.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVR
TECH
Founded
1995
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7B
11.4B
IPO Year
2006
1995

Fundamental Metrics

Financial Performance
Metric
EVR
TECH
Price
$288.42
$72.28
Analyst Decision
Buy
Strong Buy
Analyst Count
8
11
Target Price
$359.38
$71.82
AVG Volume (30 Days)
435.2K
2.2M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
1.04%
0.62%
EPS Growth
54.74
152.17
EPS
9.56
1.16
Revenue
$3,880,084,000.00
$1,215,039,000.00
Revenue This Year
$22.69
$2.49
Revenue Next Year
$13.31
$6.40
P/E Ratio
$30.12
$62.28
Revenue Growth
29.49
N/A
52 Week Low
$265.87
$43.20
52 Week High
$388.71
$72.62

Technical Indicators

Market Signals
Indicator
EVR
TECH
Relative Strength Index (RSI) 38.08 60.33
Support Level $280.02 $72.14
Resistance Level $353.60 $72.37
Average True Range (ATR) 7.36 0.13
MACD 1.31 -0.16
Stochastic Oscillator 33.04 36.11

Price Performance

Historical Comparison
EVR
TECH

About EVR Evercore Inc.

Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. Evercore operates globally, with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: